Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

4(57.1%)

N/A

2(28.6%)

Phase 3

1(14.3%)

7Total

Phase 2(4)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05286775Not ApplicableCompleted

Knee Osteoarthritis Disabling Pain Program for the Brazilian Unified Health System

Role: lead

NCT03344770Phase 2Suspended

The Efficacy of Radial Extracorporeal Shockwave Therapy on Knee Osteoarthritis

Role: lead

NCT02924168Not ApplicableCompleted

Radial Shock Waves for Functional Disability in Stroke

Role: lead

NCT02495818Phase 2Completed

Suprascapular Nerve Block Guided by Ultrasound

Role: lead

NCT02197962Phase 2Completed

Efficacy of Radial Shockwave Therapy for Treatment of Pain in Knee Osteoarthritis

Role: lead

NCT02495298Phase 2Completed

Fascial Manipulation on the Treatment of Carpal Tunnel Syndrome

Role: lead

NCT02492906Completed

Neuroimaging of Patients With Severe Knee Osteoarthrosis - Evaluation of Cerebral Volumetry

Role: lead

NCT02387567Phase 3Completed

Paraspinal Block in Nonspecific Low Back Pain

Role: lead

All 8 trials loaded